Good that you've put some numbers out there. The only major hole I can see is in the estimated cash position for Q3 and Q4. You've applied row 15 into perpetuity, whereas a $825k figure should be applied to Q3k, and $0 to Q4. This should result in Q3 balance being approximately $3.7m and Q4 balance being approximately $9m.
Factor in a one month lag in receipts meaning that figures are effectively $3m underquoted for any time period; and likely 60+ day terms on drilling costs (where circa $2-3m of net income would accrue) and you effectively have a circa $5-6m addition of genuine liquidity on top of the revised $3.7m/$9m figures.
The point does remain that they will be battling to drill purely from cashflow, but a lot will come down to the payment terms of any drilling operation and the costs of drilling in an environment where a lot of drilling crews are idle. I'd want them to have the credit facility locked away prior to drilling in case they need to sidetrack.
- Forums
- ASX - By Stock
- BYE
- Ann: Debt Refinancing and Drilling Program Update
Ann: Debt Refinancing and Drilling Program Update, page-82
Featured News
Add BYE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online